Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials
Cancer Treatment Reviews · 2026-03 · 144 · 103094
DOI: 10.1016/j.ctrv.2026.103094 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cancer Treatment Reviews, 2026-03. Verfasst von Riccardo Vida und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Ital…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Immune Checkpoint Inhibitors, Programmed Cell Death 1 Receptor, Immunotherapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy; Department of Medicine, University of Udine, Udine, Italy.
- Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy. Electronic address: michele.bartoletti@cro.it.
- Clinical Trial Office, Scientific Direction, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
- Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione G Pascale, Naples, Italy.
- Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, Aviano, Italy.
- Gynecologic Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, National Cancer Institute, Aviano, PN, Italy.
Förderung
- Ministero della Salute
Zitieren
APA
Vida, R., Bartoletti, M., Montico, M., Pignata, S., Baldassarre, G., Ditto, A., Zapelloni, G., Rizzetto, M., Lay, L., Margherita, P., & Puglisi, F. (2026). Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials. Cancer Treatment Reviews, 144, 103094. https://doi.org/10.1016/j.ctrv.2026.103094
Vancouver
Vida R, Bartoletti M, Montico M, Pignata S, Baldassarre G, Ditto A, et al. Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials. Cancer Treatment Reviews. 2026;144:103094. doi:10.1016/j.ctrv.2026.103094
BibTeX
@article{Vida2026,
author = {Vida, Riccardo and Bartoletti, Michele and Montico, Marcella and Pignata, Sandro and Baldassarre, Gustavo and Ditto, Antonino and Zapelloni, Giulia and Rizzetto, Monica and Lay, Ludovica and Margherita, Poletto and Puglisi, Fabio},
title = {Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {144},
pages = {103094},
doi = {10.1016/j.ctrv.2026.103094}
}
EUVIMED